Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes - Stephen J. Nicholls; Imre Pavo; Deepak L. Bhatt; John B. Buse; Stefano Del Prato; Steven E. Kahn; A. Michael Lincoff; Darren K. McGuire; Debra Miller; Michael A. Nauck; Hiroshi Nishiyama; Steven E. Nissen; et al. (New England Journal of Medicine, 2025)